PubRank

G Elgue

Author PubWeight™ 20.64‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 2002 2.76
2 Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin. Transplantation 2000 1.83
3 Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes 1999 1.65
4 Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation. Blood 1998 1.11
5 Low molecular weight dextran sulfate: a strong candidate drug to block IBMIR in clinical islet transplantation. Am J Transplant 2006 1.01
6 Correlation between plasma levels of growth factors and von Willebrand factor. Thromb Res 1989 0.97
7 Contact between a polymer and whole blood: sequence of events leading to thrombin generation. J Lab Clin Med 2001 0.94
8 Studies of adsorption, activation, and inhibition of factor XII on immobilized heparin. Thromb Res 1998 0.90
9 An ex vivo loop system models the toxicity and efficacy of PEGylated and unmodified adenovirus serotype 5 in whole human blood. Gene Ther 2010 0.88
10 Titanium is a highly thrombogenic biomaterial: possible implications for osteogenesis. Thromb Haemost 1999 0.88
11 Binding of antithrombin to immobilized heparin under varying flow conditions. Artif Organs 1991 0.84
12 Phosphorylation of coagulation factor XI by a casein kinase released by activated human platelets increases its susceptibility to activation by factor XIIa and thrombin. Thromb Haemost 1999 0.83
13 Low-molecular weight dextran sulfate abrogates the instant blood-mediated inflammatory reaction induced by adult porcine islets both in vitro and in vivo. Transplant Proc 2004 0.82
14 Inhibition of the plasma contact activation system of immobilized heparin: relation to surface density of functional antithrombin binding sites. J Biomed Mater Res 1997 0.82
15 Coagulation and complement activation. Biomaterials 2001 0.81
16 Surface-adsorbed fibrinogen and fibrin may activate the contact activation system. Thromb Res 2008 0.81
17 Soluble complement receptor 1 (TP10) preserves adult porcine islet morphology after intraportal transplantation into cynomolgus monkeys. Transplant Proc 2001 0.78
18 von Willebrand factor in plasma and urine of men with premature coronary artery disease. Thromb Haemost 1992 0.77
19 Cell adhesion and tissue factor upregulation in oxygenators used during coronary artery bypass grafting are modified by the Corline Heparin Surface. Scand Cardiovasc J 2002 0.77
20 Porcine islets of langerhans isolated from normal and hDAF transgenic pigs elicit the same acute inflammatory reaction during exposure to human blood; inhibition of the response with soluble complement receptor 1 and heparin. Transplant Proc 2000 0.76
21 Control of contact activation on end-point immobilized heparin: the role of antithrombin and the specific antithrombin-binding sequence. J Biomed Mater Res 1995 0.76
22 [First Argentinian thromboplastin reference reagent from human brain (author's transl)]. Sangre (Barc) 1980 0.75
23 A new in vitro model for the study of pig-to-human vascular hyperacute rejection. Xenotransplantation 2001 0.75
24 Complement regulatory proteins on human and porcine nontransgenic and hDAF transgenic islet cells: expression and role in susceptibility to lysis by human serum. Transplant Proc 2000 0.75
25 Inhibition of complement activation by soluble recombinant CR1 under conditions resembling those in a cardiopulmonary circuit: reduced up-regulation of CD11b and complete abrogation of binding of PMNs to the biomaterial surface. Immunopharmacology 1997 0.75